Replies to post #107680 on Biotech Values

[JJM760]

Then could you expound on a theory as to why He handled (and phrased) the dilution as he did? To me it was a seriously bad tactical error. He basically told the world that you can forget about Aria until 1Q2011. Perhaps, Aria with the successful Endo news and the possibility of a 534 partner, might have received some institutional interest going into the end of the year. Why would I buy now when the CEO just told me nothing going on till 2011? Market could correct and you could buy Aria @ a 20%-25% discount.